MOU Signed to Advance AI-Driven Cardiac Imaging Research

📍 Overview

Phantomics Inc., a leading cardiac imaging AI startup, has entered into a strategic research MOU with K-MEDI HUB (Korea’s Advanced Medical Industry Promotion Foundation) to jointly develop next-generation cardiovascular diagnostic technologies. Together, the collaboration aims to improve early detection and diagnosis of cardiovascular diseases by combining state-of-the-art imaging data with scalable AI solutions.

🔬 Joint Research Focus

• Collaborative R&D on AI-powered cardiac imaging

• Co-discovery and execution of research projects

• Exchange of expert personnel and shared use of imaging equipment

• Regular academic forums to track industry trends and outcomes

💡 Synergy of Technologies

• Phantomics’ Myomics®: AI solution that reduces cardiac MRI analysis time from 30 minutes to under 5, with high diagnostic precision

• K-MEDI HUB’s 4D Flow MRI: Advanced 3D blood flow analysis technology for comprehensive cardiovascular insights

🗣️ Leadership Quotes

“Improving the accuracy of cardiac MRI is directly tied to saving lives. This partnership will help us develop clinically impactful tools.”
– Panki Kim, CEO, Phantomics

“By merging Phantomics’ AI with our 4D Flow MRI tech, we can build more precise and efficient diagnostic solutions.”
– Heon-Tae Kim, Director, Medical Device Center, K-MEDI HUB

Related the article : Phantomics and K-MEDI HUB Launch Joint Cardiac Imaging Initiative